Cargando…
Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722669/ https://www.ncbi.nlm.nih.gov/pubmed/34991793 http://dx.doi.org/10.1016/j.jacc.2021.10.030 |
| _version_ | 1784625562189299712 |
|---|---|
| author | Santos, Arnoldo Martínez-Milla, Juan Pérez-Calvo, César Ibáñez, Borja |
| author_facet | Santos, Arnoldo Martínez-Milla, Juan Pérez-Calvo, César Ibáñez, Borja |
| author_sort | Santos, Arnoldo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8722669 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | by the American College of Cardiology Foundation. Published by Elsevier. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87226692022-01-04 Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19 Santos, Arnoldo Martínez-Milla, Juan Pérez-Calvo, César Ibáñez, Borja J Am Coll Cardiol Letter by the American College of Cardiology Foundation. Published by Elsevier. 2022 2022-01-03 /pmc/articles/PMC8722669/ /pubmed/34991793 http://dx.doi.org/10.1016/j.jacc.2021.10.030 Text en © 2022 by the American College of Cardiology Foundation. Published by Elsevier. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Santos, Arnoldo Martínez-Milla, Juan Pérez-Calvo, César Ibáñez, Borja Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19 |
| title | Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19 |
| title_full | Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19 |
| title_fullStr | Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19 |
| title_full_unstemmed | Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19 |
| title_short | Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19 |
| title_sort | reply: biological plausibility behind the benefits of intravenous metoprolol in severe covid-19 |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722669/ https://www.ncbi.nlm.nih.gov/pubmed/34991793 http://dx.doi.org/10.1016/j.jacc.2021.10.030 |
| work_keys_str_mv | AT santosarnoldo replybiologicalplausibilitybehindthebenefitsofintravenousmetoprololinseverecovid19 AT martinezmillajuan replybiologicalplausibilitybehindthebenefitsofintravenousmetoprololinseverecovid19 AT perezcalvocesar replybiologicalplausibilitybehindthebenefitsofintravenousmetoprololinseverecovid19 AT ibanezborja replybiologicalplausibilitybehindthebenefitsofintravenousmetoprololinseverecovid19 |